Skip to content
PubMed This is a summary of 90 peer-reviewed journal articles Updated
Obstetrics and Gynecology · Premenstrual Disorders

Premenstrual Tension, PMS, and PMDD: A Patient Guide

At a Glance

Premenstrual tension and PMS cause cyclical symptoms before a period, while PMDD is a distinct, more severe disorder that can impair daily life. Daily symptom tracking for at least two cycles helps clinicians distinguish PMDD from premenstrual worsening of another condition and guide treatment.

Premenstrual changes exist on a broad medical spectrum, ranging from the mild shifts of premenstrual tension (PMT) to the severe, life-altering experience of premenstrual dysphoric disorder (PMDD) [1]. While premenstrual syndrome (PMS) is a common condition affecting a significant portion of people who menstruate, PMDD is a distinct depressive disorder that causes clinically significant impairment in social, occupational, and personal functioning [2]. The most critical distinction between these experiences is the specific symptom pattern, the degree of impairment, and the presence of significant risks—including an increased vulnerability to suicidal ideation during the luteal phase [3][4].

(Note: Population-level observational studies associate PMDD with higher odds of suicidal ideation and suicide attempts. While this is an average association and not a personal prediction for everyone, it highlights the severity of the condition. Any suicidal thoughts warrant immediate assessment.)

The defining characteristic of these conditions is their cyclical nature. Symptoms typically emerge during the luteal phase—the window before a period—and then improve or become minimal in the postmenstrual week [2]. This fluctuating pattern distinguishes PMDD from premenstrual exacerbation (PME), where an underlying mood or anxiety disorder intensifies during the premenstrual window but does not become minimal during the rest of the month [5]. Because recall can be influenced by the intensity of the most difficult days, clinical guidelines strongly recommend at least two symptomatic cycles of prospective daily tracking to confirm this pattern [6]. However, initial care and safety planning should not be delayed while gathering this data.

Contrary to common myths, PMDD is rarely caused by a simple hormonal imbalance. Instead, current biological research points toward an altered brain sensitivity to normal hormonal fluctuations [7]. Specifically, research suggests the brains of those with PMDD may react differently to allopregnanolone (a byproduct of progesterone) and changes in the serotonin system [8][9]. This means that even if your routine hormone blood tests are generally within typical ranges, your physiological response to those shifts can still trigger profound symptoms [10].

Managing severe premenstrual disorders often requires a multimodal approach tailored to your specific needs. Treatment strategies range from medications that stabilize serotonin (SSRIs) and hormonal options that suppress ovulation, to therapeutic interventions like Cognitive Behavioral Therapy (CBT) [11][7]. For the most severe or treatment-resistant cases, advanced options such as chemical menopause may be considered by specialists [12]. While the journey to finding relief can be challenging, understanding the biological reality of your cycle is an empowering first step toward reclaiming your health [13].

Common questions in this guide

What is the difference between PMS, PMDD, and premenstrual tension?
Premenstrual tension describes milder changes before a period, while PMS refers to recurring premenstrual symptoms. PMDD is a distinct, more severe depressive disorder that can significantly affect work, relationships, self-care, and other daily activities. The symptom pattern and degree of impairment help clinicians tell these conditions apart.
How can I tell PMDD from premenstrual worsening of another condition?
With PMDD, symptoms typically appear during the luteal phase, the days before a period, and become minimal or absent during the postmenstrual week. With premenstrual exacerbation, an existing mood or anxiety disorder worsens before menstruation but continues during other parts of the month. Prospective daily tracking helps clinicians identify the pattern.
How many menstrual cycles should I track before PMDD is evaluated?
Clinical guidance generally recommends at least two symptomatic cycles of prospective daily tracking. Record symptoms each day rather than relying only on memory. Care and safety planning should begin sooner if symptoms are severe or include suicidal thoughts.
Can normal hormone test results rule out PMDD?
No. PMDD is not usually caused by a simple hormone imbalance; it may involve increased brain sensitivity to normal hormonal changes, including changes involving allopregnanolone, a progesterone byproduct. Routine hormone levels can therefore be typical even when premenstrual symptoms are severe.
What treatments can help severe PMS or PMDD?
Treatment is tailored to the person and may include SSRIs that affect serotonin, hormonal treatment to suppress ovulation, or cognitive behavioral therapy. People with severe, treatment-resistant symptoms may discuss chemical menopause with a specialist. Lifestyle adjustments may also be part of a broader treatment plan.
What should I do if I have suicidal thoughts before my period?
Any suicidal thoughts during the premenstrual phase warrant immediate assessment, even if you think they will pass after your period. Contact emergency services or a crisis service now, go to the nearest emergency department, and tell someone you trust if you may not be able to stay safe. A clinician can help create a safety and crisis-management plan.

Get notified when new evidence is published on premenstrual tension.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Premenstrual syndrome: A mini review.

    Ryu A, Kim TH

    Maturitas 2015; (82(4)):436-40.

    PMID: 26351143
  2. 2

    The multifactorial aetiology and management of premenstrual dysphoric disorder with leuprorelin acetate.

    Dunphy L, Boyle S, Wood F

    BMJ case reports 2023; (16(12)) doi:10.1136/bcr-2023-258343.

    PMID: 38160030
  3. 3

    Suicidal Risk in Women with Premenstrual Syndrome and Premenstrual Dysphoric Disorder: A Systematic Review and Meta-Analysis.

    Prasad D, Wollenhaupt-Aguiar B, Kidd KN, et al.

    Journal of women's health (2002) 2021; (30(12)):1693-1707 doi:10.1089/jwh.2021.0185.

    PMID: 34415776
  4. 4

    Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder.

    Wikman A, Sacher J, Bixo M, et al.

    BMC women's health 2022; (22(1)):35 doi:10.1186/s12905-022-01612-5.

    PMID: 35148753
  5. 5

    The Influence of Depression on Biased Diagnosis of Premenstrual Syndrome and Premenstrual Dysphoric Disorder by the PSST Inventory.

    Śliwerski A, Koszałkowska K

    Life (Basel, Switzerland) 2021; (11(11)) doi:10.3390/life11111278.

    PMID: 34833154
  6. 6

    Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS).

    Eisenlohr-Moul TA, Girdler SS, Schmalenberger KM, et al.

    The American journal of psychiatry 2017; (174(1)):51-59 doi:10.1176/appi.ajp.2016.15121510.

    PMID: 27523500
  7. 7

    Premenstrual Dysphoric Disorder.

    Lanza di Scalea T, Pearlstein T

    The Psychiatric clinics of North America 2017; (40(2)):201-216 doi:10.1016/j.psc.2017.01.002.

    PMID: 28477648
  8. 8

    Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle.

    Hantsoo L, Epperson CN

    Neurobiology of stress 2020; (12()):100213 doi:10.1016/j.ynstr.2020.100213.

    PMID: 32435664
  9. 9

    Towards understanding the biology of premenstrual dysphoric disorder: From genes to GABA.

    Hantsoo L, Payne JL

    Neuroscience and biobehavioral reviews 2023; (149()):105168 doi:10.1016/j.neubiorev.2023.105168.

    PMID: 37059403
  10. 10

    The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback.

    Nguyen TV, Reuter JM, Gaikwad NW, et al.

    Translational psychiatry 2017; (7(8)):e1193 doi:10.1038/tp.2017.146.

    PMID: 28786978
  11. 11

    Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder.

    Jespersen C, Lauritsen MP, Frokjaer VG, Schroll JB

    The Cochrane database of systematic reviews 2024; (8()):CD001396 doi:10.1002/14651858.CD001396.pub4.

    PMID: 39140320
  12. 12

    Gonadotropin-releasing hormone (GnRH) analogues for premenstrual syndrome (PMS).

    Naheed B, Kuiper JH, O'Mahony F, O'Brien PM

    The Cochrane database of systematic reviews 2025; (6()):CD011330 doi:10.1002/14651858.CD011330.pub2.

    PMID: 40492482
  13. 13

    Medical gas-lighting, diagnostic odyssey and self-advocacy among women with premenstrual dysphoric disorder from nine countries.

    Mosalisa M, Roomaney R

    Journal of health psychology 2026; (31(8)):3227-3240 doi:10.1177/13591053251401286.

    PMID: 41540801

This page explains premenstrual tension, PMS, PMDD, and symptom tracking for informational purposes only; it is not medical advice. Seek urgent help for suicidal thoughts and discuss diagnosis and treatment with a qualified clinician.